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Introduction
Acute kidney injury (AKI), a condition characterized by 
persistent oliguria and elevated serum creatinine levels, is a 
common complication in patients undergoing surgery. The 
incidence of AKI varies from 5.0–7.5% in hospitalized patients 
receiving acute care, and can reach up to 20% in patients in the 
intensive care unit [1,2]. Although the incidence of postopera-
tive AKI depends greatly on the type of surgery, overall, 40% 
of in-hospital AKI cases are related to surgical procedures [3]. 
Reported incidence rates of AKI associated with cardiac surgery 
range from 7.7–40%, depending on the patient population [4-8]. 
Improvements in surgical procedures and perioperative man-
agement have increased the number of surgical patients with 
severe comorbidities and older age, which has led to an increase 
in patients who are at a high risk of postoperative complications, 
such as infections, gastrointestinal dysfunction, acute lung in-
jury, and postoperative AKI. Recent investigations have shown 
that postoperative AKI increases the risk of morbidity after 
surgery and in-hospital mortality [6,9-11]. Patients who develop 
postoperative AKI have been found to develop sepsis and coag-
ulopathy more often than those who do not develop postopera-
tive AKI [12]. Additionally, patients with postoperative AKI are 
at higher risk of needing mechanical ventilation [12]. Moreover, 
a recent study found that the mortality rate at 30 days after intra-
abdominal surgery was 15-fold higher in patients with AKI than 
in those without, indicating that the risk of mortality is higher in 
patients with AKI even after the recovery of renal function [13].
This review discusses the definition and pathophysiology of 
postoperative AKI and explores current methods of identify-
ing postoperative AKI, including the role of novel biomarkers. 
Finally, it provides recommendations for preventative measures 
and management strategies.
Review Article
Acute kidney injury (AKI) after cardiac surgery is a common and serious complication. Several definitions of AKI have 
been proposed recently, and include both increases in serum creatinine levels and decreases in urine output as diagnostic 
criteria. The pathophysiology of postoperative AKI is complex and involves both ischemic injury and systemic inflam-
mation. Identifying risk factors, such as old age, underlying diabetes, heart failure, and obesity, may aid in the application 
of preventative methods for postoperative AKI. Additionally, recognizing different risks after different types of surgical 
procedures would be valuable. Novel biomarkers that could detect AKI more precisely at an earlier time point are being 
investigated. Several new biomarkers have been assessed in large multi-center studies and are believed to accommodate 
conventional clinical findings in diagnosing postoperative AKI. In high-risk patients, preventative measures, such as the 
maintenance of adequate hemodynamics and sufficient fluid resuscitation, could lower the incidence of postoperative 
AKI. Avoiding nephrotoxic agents and optimizing preoperative hemoglobin levels to avoid excessive transfusions would 
also be beneficial. In situations in which medical management fails to maintain sufficient urine output and acid–base and 
electrolyte homeostasis, early initiation of renal replacement therapy should be considered.
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Definition of AKI
Various definitions have been applied to effectively determine 
the extent of renal function decline that affects patient morbidity 
and mortality. The glomerular filtration rate (GFR) is the most 
accurate representation of renal function. However, estimating 
the GFR using a 24-h urine creatinine clearance test is trouble-
some and time-consuming in acute situations when immediate 
treatment decisions are needed. Thus, most recent definitions 
use urine output and serum creatinine levels as surrogates of 
renal function because of their easy-to-measure characteristics.
The first consensus on the definition of AKI, the Risk, In-
jury, Failure, Loss and End-stage Kidney (RIFLE) criteria, was 
reported in 2004 by the Acute Dialysis Quality Initiative [14]. 
The RIFLE system classifies AKI into three stages of severity, 
determined by serum creatinine levels or changes in urine out-
put, and two outcome stages, decided by the duration of kidney 
function loss. This system also introduced the term ‘AKI’ to re-
place the formerly used term ‘acute renal failure.’ This change in 
terminology reflects the fact that structural injury to the kidney 
precedes the loss of kidney function, highlighting the impor-
tance of salvaging actions even before actual failure of function 
occurs.
In 2007, the RIFLE system was revised by the Acute Kidney 
Injury Network (AKIN) [15]. With increasing evidence show-
ing that even small elevations in serum creatinine levels may be 
associated with increases in morbidity and mortality [16], the 
AKIN system allows the definition of AKI without knowledge of 
baseline serum creatinine levels.
Studies comparing these two classification systems have 
shown that both definitions can effectively identify AKI within 
the first 24 h [17,18]. Additionally, the severity of AKI clearly 
predicts clinical outcomes in both systems [19]. However, over-
diagnosis can occur when AKI is defined solely on the basis of 
the degree of serum creatinine change [19]. Choosing the ap-
propriate baseline creatinine level for comparison is key in these 
situations.
The most recent consensus on the definition and staging 
of AKI was reached in 2012 by the Kidney Disease: Improving 
Global Outcomes (KDIGO) Foundation [20]. It defined AKI 
as any of the following: an increase in serum creatinine by ≥ 
0.3 mg/dl (≥ 26.5 μmol/L) within 48 h; or an increase in serum 
creatinine to ≥ 1.5 times the baseline value, which is known or 
presumed to have occurred within the prior 7 days; or urine 
volume < 0.5 ml/kg/h for 6 h. In particular, the KDIGO criteria 
eliminated the use of GFR and added a timeframe according to 
the absolute level or relative increase of serum creatinine. Addi-
tionally, this system added a new class to recognize patients with 
acute kidney damage superimposed on an underlying chronic 
kidney disease. Moreover, KDIGO recommends staging AKI 
according to severity, based on investigations demonstrating 
that mortality and renal replacement therapy risks increase with 
each stage [21]. Table 1 compares the three different definition 
criteria.
Despite these efforts to detect AKI effectively and in a timely 
manner, definitions that include serum creatinine levels still 
have limitations. Most importantly, serum creatinine levels be-
gin to increase after the pathological changes of kidney injury 
Table 1. Comparison of the Three Classifications and Staging of AKI
Classification RIFLE AKIN KDIGO
Stage Risk
Increased sCr × 1.5 or GFR decrease  
> 25% or urine output < 0.5 ml/kg/h  
for 6 h
Stage 1
Increased sCr × 1.5 or ≥ 0.3 mg/dl  
from baseline or urine output  
< 0.5 ml/kg/h for 6 h
Stage 1
Increased sCr × 1.5 to 1.9 baseline or  
≥ 0.3 mg/dl from baseline or urine 
output < 0.5 ml/kg/h for 6 to 12 h
Injury
Increased sCr × 2 or GFR decrease  
> 50% or urine output < 0.5 ml/kg/h  
for 12 h
Stage 2
Increased sCr × 2 or urine output  
< 0.5 ml/kg/h for 12 h
Stage 2
Increased sCr × 2.0 to 2.9 baseline or 
urine output < 0.5 ml/kg/h for 12 h
Failure
Increased sCr × 3 or GFR decrease  
> 75% or sCr ≥ 4 mg/dl (acute rise of  
sCr ≥ 0.5 mg/dl) or urine output  
< 0.3 ml/kg/h for 24 h or anuria for 12 h
Stage 3
Increased sCr × 3 or ≥ 4 mg/dl with  
acute rise of sCr ≥ 0.5 mg/dl or  
urine output < 0.3 ml/kg/h for 24 h or 
anuria for 12 h
Stage 3
Increased sCr × 3 baseline or ≥ 4 mg/dl 
or initiation of RRT, or GFR decrease  
< 35 ml/min/1.73 m2 for patients  
< 18 years of age  or urine output  
< 0.3 ml/kg/h for 24 h or anuria for 12 h
Loss
Persistent AKI > 4 weeks
ESRD
End-stage renal disease
RIFLE: Risk, Injury, Failure, Loss and End-stage Kidney, AKIN: Acute Kidney Injury Network, KDIGO: Kidney Disease: Improving Global Outcomes, 
sCr: serum creatinine level, GFR: glomerular filtration rate, AKI: acute kidney injury, ESRD: end-stage renal disease. 
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are already well established. Thus, timely measures to prevent 
the progression of kidney injury at an early time point may not 
be possible. Additionally, the serum creatinine level is affected 
by volume status, infectious conditions, steroid use, and muscle 
mass [22]. Therefore, recent investigations have focused on 
developing biomarkers that can effectively detect AKI at earlier 
time points.
Pathophysiology
Traditionally, the causes of AKI have been classified into 
prerenal, intrinsic, and postrenal factors. These classifications 
provide practical information about the underlying pathophysi-
ology of the etiology of AKI, but to date the causes of AKI have 
not been differentiated clearly in a clinical setting. When the 
duration of AKI induced by a prerenal cause is prolonged, renal 
parenchymal damage progresses, eventually giving rise to intrin-
sic kidney injury [22].
Prerenal AKI occurs when the perfusion of the kidney is 
altered. The kidney, which has the highest tissue perfusion rate 
relative to organ weight, normally receives 15–20% of total 
cardiac output [23]. This high perfusion rate makes the kidney 
vulnerable to hemodynamic injury. Prerenal AKI is found most 
commonly in patients undergoing cardiac surgery who have un-
dergone cardiopulmonary bypass procedures [24,25]. However, 
recent investigations have shown that in addition to hemody-
namic alterations, inflammation and direct nephrotoxic effects 
on tubular cells play crucial roles in inducing AKI in patients 
after cardiac surgery [26]. Additionally, factors not related to the 
surgical procedure itself, such as the presence of valvular disease, 
inotropic use, or postoperative intra-aortic balloon pump sup-
port, can reduce renal blood flow, subsequently aggravating the 
damage caused by cardiopulmonary bypass. Moreover, impaired 
glomerular hemodynamics resulting from the use of non-steroi-
dal anti-inflammatory drugs, diuretics, and renin-angiotensin-
aldosterone system blockades may further exacerbate renal 
damage.
Intrinsic AKI accompanies injury of the major structural 
components of the kidney. Embolic events and vasculopathies 
caused by malignant hypertension or microangiopathies induce 
damage to the renal vasculature. Allergic reactions to medica-
tions or infectious organisms can generate renal interstitial 
injury. Damage to the renal tubules can occur due to profound 
hemodynamic deterioration in the kidney, or nephrotoxic sub-
stances, such as antibiotics or contrast media. Tubular damage is 
the most common underlying cause of intrinsic AKI occurring 
after surgery [20]. However, all of the events mentioned above 
can occur postoperatively. Table 2 summarizes the common eti-
ologies of postoperative AKI.
Risk Factors
Several factors are known to contribute to postoperative 
AKI. Identifying these factors could aid in avoiding nephrotoxic 
drugs and providing close monitoring for renal derangements in 
high-risk patients.
Comorbidities
Demographic factors, such as age and gender, have been 
found to be closely related with the development of postopera-
tive AKI. The capacity of the kidney to adapt to hemodynamic 
changes declines with age [27]. Not only is renal plasma flow 
lower, but renal responses to vasodilating factors are also weaker 
in older patients [28]. Additionally, older patients are more often 
exposed to medications that can affect renal function, such as 
diuretics and contrast media. In a recent prospective evaluation 
of 9,400 patients, female gender was also noted as a significant 
risk factor for postoperative AKI [29].
Underlying medical conditions, such as chronic kidney dis-
ease, diabetes mellitus, hypertension, cardiovascular disease, liv-
er disease, and chronic obstructive pulmonary disease, are well-
documented risk factors predisposing a patient to postoperative 
AKI [5,11,27,30,31]. In a prospective evaluation of 43,642 pa-
tients undergoing cardiac surgery, the risk of postoperative AKI 
was increased significantly among patients with cardiomegaly 
(odds ratio, OR = 1.74; 95% CI = 1.43–2.12), cerebrovascular 
disease (OR = 1.89; 95% CI = 1.48–2.41), chronic obstructive 
Table 2. Factors Associated with Postoperative AKI
Preoperative Intraoperative Postoperative
Nephrotoxic drugs Cardiopulmonary bypass Decreased cardiac function
Inflammation Anemia Vasoactive drugs
Underlying CKD Shock Nephrotoxic drugs
Decreased effective volume Hemodilution Inflammation
Renovascular disease Embolic events Unstable hemodynamic state
Congestive heart failure
AKI: acute kidney injury, CKD: chronic kidney disease. 
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pulmonary disease (OR = 1.55; 95% CI = 1.28–1.88), diabetes 
mellitus (OR = 1.43; 95% CI = 1.08–1.89), and New York Heart 
Association class IV status (OR = 2.12; 95% CI = 1.78–2.54). 
However, the risk of AKI was unrelated to remote myocardial 
infarction or a history of percutaneous coronary artery angio-
plasty [5].
Obesity
Obesity, particularly severe obesity, defined by a body mass 
index (BMI) of > 40 kg/m2, is associated with a higher risk of 
postoperative AKI than lower BMI [32,33]. The reason for this 
increased risk is known to be related to the changes in renal he-
modynamics induced by adipose tissue in obese patients [34,35]. 
The type and location of adipose tissue is also suspected to affect 
renal function after surgery. In a recent investigation, abdominal 
obesity, quantified using computed tomography scans, was par-
ticularly associated with postoperative AKI [36].
Metabolic acidosis
A recent investigation evaluating factors associated with AKI 
development after cardiac surgery revealed that low preopera-
tive serum bicarbonate levels (< 23 mEq/L) were independently 
associated with a two-fold increased risk of postoperative AKI 
[37]. The underlying mechanism for the association between 
low serum bicarbonate concentrations and postoperative AKI is 
unclear, but several possibilities can be considered on the basis 
of previous animal experiments. Metabolic acidosis is known to 
induce medullary ammonia production, which in turn activates 
the alternative complement pathway and aggravates tubular in-
flammation in an animal model of AKI [38]. Additionally, exces-
sive acid loading in mice resulted in activation of the intrarenal 
renin-angiotensin-aldosterone system [39]. Moreover, sodium 
bicarbonate is known to increase renal medullary oxygen de-
livery and to reduce renal iron-mediated free radical formation 
[40]. Based on these findings, some investigators have attempted 
to prevent AKI through urine alkalization by means of sodium 
bicarbonate infusion; however, the results of these trials have 
been inconsistent [41,42].
Type of surgery
The type of surgery has a significant effect on the risk of 
postoperative AKI occurrence. The risk of postoperative AKI 
is increased in emergency surgery versus elective operations 
[30,31]. Compared with other surgical procedures, intraperito-
neal surgery, especially exploratory laparotomy and small-bowel 
resection operations, is known to increase the risk of postopera-
tive AKI [31,43,44]. Increased intra-abdominal pressure, caused 
by excessive fluid administration in these operations, results in 
a situation in which the intra-abdominal pressure compresses 
the renal veins and constricts the renal arteries, activating the 
sympathetic system; this is known as abdominal compartment 
syndrome [45-47]. This condition ultimately leads to a reduc-
tion in renal perfusion and can cause ischemic damage to the 
kidneys [45]. Similarly, urine output decreases during a laparos-
copy due to increased abdominal pressure resulting from intra-
abdominal gas insufflation [48]. However, the reduction in urine 
output during laparoscopy has not been found to increase the 
risk of postoperative AKI [49,50]. Nonetheless, increasing intra-
abdominal pressure should be avoided in older and high-risk 
patients, such as those with underlying CKD.
Major vascular surgery and cardiac operations also increase 
the risk of postoperative AKI in particular [8,51]. Previous stud-
ies have demonstrated that AKI occurs in almost 30% of patients 
who have undergone cardiac surgery, although the incidence of 
AKI associated with cardiac surgery varies somewhat depend-
ing on the characteristics of the study population [8,19,51]. Al-
though several pathophysiological factors have been identified, 
such as ischemic-reperfusion injury, inflammation, microem-
bolism, decreased renal perfusion, and the use of nephrotoxic 
drugs, the mechanism of the increased postoperative AKI risk 
in patients undergoing cardiac operation is not yet fully under-
stood [52]. The type of cardiac operation is also linked to differ-
ent effects in inducing postoperative AKI. Because cardiopul-
monary bypass per se is a known risk factor for AKI, coronary 
artery bypass graft (CABG) operations using cardiopulmonary 
bypass were associated with a higher incidence of AKI com-
pared with off-pump CABG [24,25]. Patients receiving cardiac 
valve surgery also have higher incidences of postoperative AKI 
than those undergoing on-pump CABG operations [24,25,53].
Drugs
Preoperative and intraoperative uses of medications have 
been evaluated extensively as a cause of postoperative AKI. 
Medications that block the renin-angiotensin-aldosterone sys-
tem and non-steroidal anti-inflammatory drugs increase the risk 
of postoperative AKI [54,55]. The influence on the compensa-
tory mechanism that maintains the GFR under hemodynami-
cally compromised conditions is the main mechanism for this 
increased risk. Aminoglycosides induce renal damage via mi-
tochondrial dysfunction [35]. The combination of two or more 
nephrotoxic drugs, consisting of diuretics with angiotensin-con-
verting enzyme inhibitors or angiotensin receptor blockers and 
non-steroidal anti-inflammatory drugs, was found to increase 
the risk of AKI considerably in an evaluation of a large cohort of 
patients with hypertension [54].
Patients who undergo radiological examinations involving 
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contrast media before surgery are at an increased risk of de-
veloping postoperative AKI [56]. The mechanism of contrast-
induced nephropathy is not understood, but it is believed to 
include direct damage from reactive oxygen species [57,58]. 
Because hypovolemia aggravates the renal damage induced by 
contrast media, it is important to maintain effective blood vol-
ume in patients exposed to contrast media before surgery.
Biomarkers
Detecting AKI by using serum creatinine levels is prob-
lematic because serum creatinine levels are elevated after renal 
function has declined, and do not reflect injury. Therefore, re-
cent investigations have focused on finding practical serum and 
urine biomarkers that could reveal early injury before profound 
functional damage occurs.
Neutrophil gelatinase-associated lipocalin (NGAL) is re-
leased from neutrophils and is induced by inflammation. Studies 
have shown that elevated urine and serum NGAL levels reflect 
tubular injury [59,60]. In a study of children undergoing car-
diopulmonary bypass, urine concentrations of NGAL increased 
2 h after cardiopulmonary bypass, whereas AKI diagnosis with 
serum creatinine was only possible 1–3 days after the procedure. 
In this study, the amount of NGAL in urine at 2 h after cardio-
pulmonary bypass was the most powerful independent predic-
tor of acute renal injury [61]. However, because NGAL is pro-
duced throughout the body, it is difficult to distinguish systemic 
inflammation from localized renal inflammation with elevated 
levels of NGAL [62]. This limitation has restricted the use of 
NGAL in detecting AKI. Cystatin C (CyC) is a protease inhibi-
tor produced by nucleated cells at a constant rate. This is filtered 
freely by the glomerulus and reabsorbed completely by the renal 
tubules. CyC is not normally found in urine, so detection of CyC 
in urine may indicate renal injury [63,64]. Kidney injury mol-
ecule-1 (KIM-1) is highly upregulated in proximal tubular cells 
after kidney injury. A recent study reported that plasma KIM-1 
levels increased within 2 days after surgery only in patients who 
developed AKI, suggesting KIM-1 as a biomarker capable of 
early AKI detection [65].
Recently, some researchers have assessed combinations of 
two or more biomarkers to improve the diagnostic power for 
AKI. This approach is promising in that different biomarkers 
indicate different aspects of renal injury. In a prospective evalu-
ation of 90 patients undergoing cardiac surgery, Han et al. [66] 
reported that the combination of urinary KIM-1, N-acetyl-beta-
d-glucosaminidase, and NGAL enhanced the sensitivity of early 
detection of postoperative AKI compared with individual bio-
markers.
Tissue inhibitor of metalloproteinase-2 (TIMP-2) and insu-
lin-like growth factor binding protein 7 (IGFBP7) are cell-cycle 
arrest proteins. In events of tubular injury due to toxin exposure, 
hypoxia, and inflammation, these proteins are released into the 
urine [67]. Recent multi-center studies have demonstrated that 
TIMP-2 and IGFBP7 are superior to existing markers, and pro-
vide additional information in detecting AKI to that provided by 
clinical variables [68,69]. The US Food and Drug Administra-
tion recently approved the combination of these two novel uri-
nary biomarkers to assess the risk of AKI in critically ill patients.
Therapeutic Approach
Maintaining adequate hemodynamics to prevent tissue hy-
poperfusion and renal ischemic injury is the primary goal of 
perioperative management [70]. Blood pressure is a practical 
surrogate indicating hemodynamic status. Prolonged periods of 
perioperative hypotension have been found to be significantly 
associated with postoperative AKI. An investigation evaluat-
ing the perioperative data of 33,330 patients undergoing non-
cardiac surgery revealed that 1–5 min of an intraoperative mean 
arterial pressure of < 55 mmHg was significantly associated with 
the development of postoperative AKI [71].
Adequate fluid management is a key component in maintain-
ing intravascular volume and cardiac hemodynamics in patients 
undergoing surgery. However, although under resuscitation 
increases the risk of renal hypoperfusion, excessive fluid admin-
istration is capable of decreasing renal blood flow and GFR by 
increasing renal subcapsular pressure and inducing abdominal 
compartment syndrome [72]. Recent non-invasive methods for 
monitoring hydration status, such as chest ultrasound for detect-
ing pulmonary congestion and body composition monitoring 
through bioimpedance spectroscopy techniques, may help to 
maintain appropriate hydration status [73,74].
The type of fluid used for volume resuscitation also affects 
postoperative renal function. Because normal saline actually 
contains supraphysiological levels of chloride, infusion of large 
volumes of normal saline may cause hyperchloremic acidosis, 
which can lead to a decrease in renal perfusion. Animal stud-
ies have shown that hyperchloremia produces progressive renal 
vasoconstriction and decreases in GFR [75]. In an investigation 
comparing the effects of intravenous administration of normal 
saline and a balanced crystalloid solution, only normal saline 
resulted in a reduction in renal cortical tissue perfusion [76].
Anemia induces renal medullary hypoxia, which is one of the 
key mechanisms leading to AKI [77]. In an observational study 
of patients undergoing non-cardiac surgery, low preoperative 
and early postoperative decreases in hemoglobin concentrations 
were strongly associated with postoperative AKI in a graded 
manner [78]. Additionally, intraoperative transfusions have been 
found to increase the risk of postoperative AKI development. 
An investigation of a cohort of patients who underwent cardiac 
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surgery with cardiopulmonary bypass revealed that AKI rates 
increased in direct proportion to the amount of erythrocytes 
transfused, and this increase was more pronounced in patients 
with anemia [79]. It is uncertain whether anemia induced renal 
hypoxia, or whether toxic effects of transfusion itself increased 
the risk of postoperative AKI in these patients. Considering that 
stored red blood cells undergo irreversible changes, making 
them more adherent to the vascular endothelium, resulting in a 
decrease in microvascular flow, both low hemoglobin levels and 
increased amounts of transfusions could play a role in inducing 
postoperative AKI [80,81]. Thus, optimizing the preoperative 
hemoglobin levels as suggested by the recent ‘patient blood 
management protocol’ would be helpful in lowering the risk of 
postoperative AKI [82].
Once oliguria occurs, interventions improving renal he-
modynamics, such as maintaining vascular contractility with 
inotropes and optimizing heart rate, should be implemented 
to maintain urine volume. However, if oliguria persists despite 
these actions, diuretics should be used to maintain urine out-
put. Nonetheless, it should be noted that a recent meta-analysis 
found that although the use of furosemide may be beneficial in 
achieving fluid balance, it did not reduce mortality in patients 
with AKI [83]. Additionally, furosemide can aggravate renal 
failure by inducing prerenal injury in patients with reduced ef-
fective volume.
Renal replacement therapy should be considered when the 
effort to maintain renal function has failed. The general indica-
tions for renal replacement therapy are volume overload, hyper-
kalemia, and medically unresolved metabolic acidosis. However, 
early initiation of renal replacement therapy may be beneficial in 
some cases. In a recent investigation of patients who developed 
severe AKI after cardiac surgery, early and aggressive continu-
ous venovenous hemofiltration was associated with better-than-
predicted survival [84,85].
Conclusions
AKI is a common complication in patients undergoing sur-
gery. The clinical significance of postoperative AKI is substantial 
in that the incidence is growing with the increase in opera-
tions in older and severely comorbid patients. Additionally, the 
development of postoperative AKI increases mortality risks 
significantly, lengthens hospital stays, and worsens long-term 
morbidity. The recent definitions and classifications of AKI 
were intended to provide effective and timely detection of AKI. 
Nonetheless, assessments based on serum creatinine levels have 
limitations. The development of novel biomarkers may provide 
a more accurate and faster way of detecting postoperative AKI, 
which could eventually lead to earlier intervention. Additionally, 
recognizing the risk factors of postoperative AKI and under-
standing the management options would be beneficial in pre-
venting postoperative AKI and improving patient outcomes. 
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